Form 4: Director Georgia Melenikiotou Acquires Shares in Inspire Medical Systems

Director Georgia Melenikiotou acquired 80 shares of Inspire Medical Systems common stock on January 15, 2025, in lieu of cash fees.

Summary

• Georgia Melenikiotou, a director at Inspire Medical Systems, acquired 80 shares of common stock on January 15, 2025.
• The shares were received in lieu of cash fees, as part of the company's Non-Employee Director Compensation Policy.
• The price per share was $176.33.
• Following the transaction, Ms. Melenikiotou directly owns 2,293 shares of Inspire Medical Systems stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a routine transaction that aligns director interests with shareholders. There are no negative implications.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The use of stock in lieu of cash fees can be seen as a positive for the company's cash flow.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the compensation practices of the company for its non-employee directors.

Comparison to Industry Standards

• Stock-based compensation for directors is a common practice across publicly traded companies, particularly in the technology and healthcare sectors.
• The use of stock in lieu of cash fees is a standard method to align the interests of directors with those of shareholders.
• Companies like Medtronic and Boston Scientific also use similar compensation methods for their directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.
• The use of stock instead of cash may be viewed positively by creditors as it preserves cash.

Key Dates

Keywords

insider trading, Form 4, stock acquisition, director, Inspire Medical Systems, INSP, equity compensation